Logo image of SG

SWEETGREEN INC - CLASS A (SG) Stock Fundamental Analysis

NYSE:SG - US87043Q1085 - Common Stock

8.68 USD
+0.46 (+5.6%)
Last: 9/9/2025, 7:28:24 PM
8.69 USD
+0.01 (+0.12%)
After Hours: 9/9/2025, 7:28:24 PM
Fundamental Rating

3

Taking everything into account, SG scores 3 out of 10 in our fundamental rating. SG was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. While SG seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SG had negative earnings in the past year.
In the past year SG had a positive cash flow from operations.
In the past 5 years SG always reported negative net income.
In multiple years SG reported negative operating cash flow during the last 5 years.
SG Yearly Net Income VS EBIT VS OCF VS FCFSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of -11.79%, SG is not doing good in the industry: 85.82% of the companies in the same industry are doing better.
SG has a Return On Equity (-23.16%) which is in line with its industry peers.
Industry RankSector Rank
ROA -11.79%
ROE -23.16%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
SG Yearly ROA, ROE, ROICSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 27.67%, SG is doing worse than 79.10% of the companies in the same industry.
In the last couple of years the Gross Margin of SG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
SG Yearly Profit, Operating, Gross MarginsSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

6

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SG has been increased compared to 1 year ago.
The number of shares outstanding for SG has been increased compared to 5 years ago.
There is no outstanding debt for SG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SG Yearly Shares OutstandingSG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SG Yearly Total Debt VS Total AssetsSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

SG has an Altman-Z score of 0.44. This is a bad value and indicates that SG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.44, SG is not doing good in the industry: 78.36% of the companies in the same industry are doing better.
There is no outstanding debt for SG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACC8.81%
SG Yearly LT Debt VS Equity VS FCFSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SG has a Current Ratio of 1.82. This is a normal value and indicates that SG is financially healthy and should not expect problems in meeting its short term obligations.
SG's Current ratio of 1.82 is amongst the best of the industry. SG outperforms 81.34% of its industry peers.
SG has a Quick Ratio of 1.80. This is a normal value and indicates that SG is financially healthy and should not expect problems in meeting its short term obligations.
SG's Quick ratio of 1.80 is amongst the best of the industry. SG outperforms 82.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.8
SG Yearly Current Assets VS Current LiabilitesSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for SG have decreased by -5.00% in the last year.
SG shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
Measured over the past years, SG shows a quite strong growth in Revenue. The Revenue has been growing by 19.81% on average per year.
EPS 1Y (TTM)-5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%0.51%

3.2 Future

Based on estimates for the next years, SG will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.04% on average per year.
Based on estimates for the next years, SG will show a quite strong growth in Revenue. The Revenue will grow by 12.48% on average per year.
EPS Next Y2.74%
EPS Next 2Y9.98%
EPS Next 3Y8.57%
EPS Next 5Y12.04%
Revenue Next Year5.26%
Revenue Next 2Y11.8%
Revenue Next 3Y13.77%
Revenue Next 5Y12.48%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SG Yearly Revenue VS EstimatesSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
SG Yearly EPS VS EstimatesSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SG Price Earnings VS Forward Price EarningsSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SG Per share dataSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.98%
EPS Next 3Y8.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SWEETGREEN INC - CLASS A

NYSE:SG (9/9/2025, 7:28:24 PM)

After market: 8.69 +0.01 (+0.12%)

8.68

+0.46 (+5.6%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-07 2025-11-07/amc
Inst Owners110.54%
Inst Owner Change-3.91%
Ins Owners1.57%
Ins Owner Change0.16%
Market Cap1.03B
Analysts79.09
Price Target14.65 (68.78%)
Short Float %18.9%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.66%
Min EPS beat(2)-60.58%
Max EPS beat(2)9.26%
EPS beat(4)1
Avg EPS beat(4)-24.67%
Min EPS beat(4)-60.58%
Max EPS beat(4)9.26%
EPS beat(8)2
Avg EPS beat(8)-20.78%
EPS beat(12)4
Avg EPS beat(12)-14.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.21%
Min Revenue beat(2)-6.23%
Max Revenue beat(2)-2.2%
Revenue beat(4)0
Avg Revenue beat(4)-3.96%
Min Revenue beat(4)-6.23%
Max Revenue beat(4)-2.2%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)1
Avg Revenue beat(12)-3.79%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-34.17%
PT rev (3m)-51.03%
EPS NQ rev (1m)-15.48%
EPS NQ rev (3m)-71.66%
EPS NY rev (1m)-16.91%
EPS NY rev (3m)-18.87%
Revenue NQ rev (1m)-5.24%
Revenue NQ rev (3m)-10.12%
Revenue NY rev (1m)-3.81%
Revenue NY rev (3m)-4.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.5
P/FCF N/A
P/OCF 56.43
P/B 2.42
P/tB 2.81
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.15
OCFY1.77%
SpS5.81
BVpS3.58
TBVpS3.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.79%
ROE -23.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.67%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.14%
Cap/Sales 14.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.8
Altman-Z 0.44
F-Score4
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)172.66%
Cap/Depr(5y)198.17%
Cap/Sales(3y)17.26%
Cap/Sales(5y)20.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y2.74%
EPS Next 2Y9.98%
EPS Next 3Y8.57%
EPS Next 5Y12.04%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%0.51%
Revenue Next Year5.26%
Revenue Next 2Y11.8%
Revenue Next 3Y13.77%
Revenue Next 5Y12.48%
EBIT growth 1Y-1.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.54%
EBIT Next 3Y45.86%
EBIT Next 5Y27.84%
FCF growth 1Y37.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y193.97%
OCF growth 3YN/A
OCF growth 5YN/A